CLBT

Cellebrite DI Ltd. Technology - Digital Intelligence Investor Relations →

NO
4.6% ABOVE
↓ Approaching Was 5.0% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $12.27
14-Week RSI 44
Rel. Volume (14w) This week's trading vs. the 14-week average 1.4x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.96

Cellebrite DI Ltd. (CLBT) closed at $12.83 as of 2026-06-19, trading 4.6% above its 200-week moving average of $12.27. The stock is currently moving closer to the line, down from 5.0% last week. The 14-week RSI sits at 44, indicating neutral momentum.

Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.96 ratio) is neutral — neither side is clearly dominating.

Over the past 245 weeks of data, CLBT has crossed below its 200-week moving average 5 times. On average, these episodes lasted 19 weeks. Historically, investors who bought CLBT at the start of these episodes saw an average one-year return of +79.9%.

With a market cap of $3.2 billion, CLBT is a mid-cap stock. The company generates a free cash flow yield of 4.7%. Return on equity stands at 16.4%, a solid level. The stock trades at 6.2x book value.

Share count has increased 28.8% over three years, indicating dilution. CLBT passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.

Over the past 4.8 years, a hypothetical investment of $100 in CLBT would have grown to $115, compared to $173 for the S&P 500. CLBT has returned 3.0% annualized vs 12.3% for the index, underperforming the broader market over this period.

Free cash flow has been growing at a 140.7% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CLBT vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CLBT Crosses Below the Line?

Across 5 historical episodes, buying CLBT when it crossed below its 200-week moving average produced an average return of +78.2% after 12 months (median +126.0%), compared to +21.8% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +91.8% vs +43.0% for the index.

Each line shows $100 invested at the moment CLBT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CLBT would reach each dislocation threshold.

Current Bean Score -1.15σ
Current FCF Yield 4.40%
Baseline Yield 4.34%
Historical σ 0.46pp

Dislocation Price Levels

Prices where CLBT's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-05-14.

LevelσPriceSignal
Deep Value+2σ$10.41Unusually cheap — potential buy zone
Value+1σ$11.29Cheap vs. own history
Fair Value+0σ$12.34Historical mean behavior
Expensive-1σ$13.60Expensive vs. own history
Deep Expensive-2σ$15.15Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CLBT's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +0.34σ Distance from line vs own history
Sector-Relative N/A Vs sector median this week
Buyback Acceleration -2.8pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +1.4pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+20.9pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

CLBT has crossed below its 200-week MA 5 times with an average 1-year return of +79.9% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Nov 2021Jul 20238752.5%-50.1%+38.6%
Jul 2023Aug 202310.3%+75.6%+73.6%
Sep 2023Sep 202310.5%+136.9%+73.6%
Oct 2023Nov 2023513.1%+157.3%+82.8%
Apr 2026Apr 202617.1%N/A+16.3%
Average19+79.9%

Frequently Asked Questions

Is CLBT below its 200-week moving average?

No. Cellebrite DI Ltd. (CLBT) is currently 4.6% above its 200-week moving average of $12.27. It would need to fall to $12.27 to cross below the line.

What is CLBT's 200-week moving average price?

Cellebrite DI Ltd.'s 200-week moving average is $12.27 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CLBT drops below its 200-week moving average?

CLBT has crossed below its 200-week moving average 5 times in our data. On average, buying at that moment produced a one-year return of +79.9%. These dips have historically been decent entry points. These episodes lasted 19 weeks on average.

Is CLBT a good value right now?

Here's what our data says about CLBT as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 44. Free cash flow yield is 4.7%. Return on equity is 16.4%. Price-to-book is 6.2x. This is not a buy or sell recommendation — always do your own research.

How does CLBT compare to the S&P 500?

Over the past 4.8 years, $100 invested in CLBT would have grown to $115, compared to $173 for the S&P 500. That's 3.0% annualized vs 12.3% for the index. CLBT has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19